Breaking News Instant updates and real-time market news.

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

, AAPL

Apple

$193.43

-0.725 (-0.37%)

14:51
11/13/18
11/13
14:51
11/13/18
14:51

After Qorvo warns, MKM says Apple risk 'largely' factored into supply chain

MKM Partners analyst Ruben Roy noted that Qorvo (QRVO) followed Lumentum (LITE) in reducing its December quarter outlook due to recent demand forecast changes for Apple's (AAPL) iPhone. He also noted that Qorvo expects March quarter revenues to be down less than 10%, sequentially, which he points out is better than the seasonal declines in the previous two fiscal years and likely due to content increases across a number of upcoming Samsung handsets. Roy said he remains positive on Qorvo given his continued expectations for market share gains, but lowered his price target on the stock to $86 from $95. In terms of other Apple supply chain companies, he believes that Skyworks' (SWKS) guidance likely considered the demand changes at Apple, but thinks Cirrus Logic (CRUS) provided December quarter guidance ahead of Apple changes. Roy also notes that Broadcom (AVGO) will report on December 6. While seeing some risk to near-term wireless estimates, Roy concluded that he believes Apple risk is "largely incorporated" into supply chain expectations at this point.

QRVO

Qorvo

$63.45

-0.35 (-0.55%)

AAPL

Apple

$193.43

-0.725 (-0.37%)

LITE

Lumentum

$38.92

1.415 (3.77%)

SWKS

Skyworks

$72.16

-0.61 (-0.84%)

CRUS

Cirrus Logic

$37.63

1.99 (5.58%)

AVGO

Broadcom

$224.39

0.84 (0.38%)

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 19

    Nov

  • 06

    Dec

QRVO Qorvo
$63.45

-0.35 (-0.55%)

11/13/18
JPMS
11/13/18
NO CHANGE
JPMS
Overweight
JPMorgan sees 'significant upside' in Qorvo shares as expectations reset
JPMorgan analyst Bill Peterson notes that following other announced cuts in the Apple (AAPL) supply chain, Qorvo (QRVO) also reset near-term revenue expectations as a result of lower demand from Apple. The analyst believes that not only is Qorvo seeing weaker unit demand, but likely is seeing reduced demand for the iPhone XR model in particular. Nonetheless, Peterson expects Qorvo to outperform through his modeling period on content gains in mobile, broad-based across smartphone makers, compensating for weaker smartphone unit demand and on strong double-digit percentage year over year revenue growth in non-mobile on infrastructure, 5G, and GaN. As expectations have been reset, and with investors becoming more comfortable with the content growth story in mobile and outsized growth in non-mobile, the analyst sees "significant upside" in Qorvo shares over the mid-term, and reiterates an Overweight rating on the stock.
11/12/18
SBSH
11/12/18
DOWNGRADE
Target $85
SBSH
Neutral
Citi downgrades Skyworks to Neutral, cuts targets on Nvidia, Qorvo
Citi analyst Atif Malik downgraded Skyworks Solutions (SWKS) to Neutral from Buy and lowered his price target for the shares to $85 from $116. The company is being impacted by broad smartphone weakness, disappointing unit sales of Apple's (AAPL) iPhone XR, and a high Apple concentration, which represented 39% of sales in fiscal 2019, Malik tells investors in a research note. Further, the analyst thinks 5G radio frequency is a 2020 story versus his prior view of 2019. Malik also lowered his price target for Buy-rated Nvidia (NVDA) to $270 from $300 to reflect recent market multiple compression. In addition, the analyst dropped his price target for Neutral-rated Qorvo (QRVO) to $75 from $86. Weak iPhone XR units, where Qorvo won incremental mid-high band dollar content, will have a negative impact on the company's gross margins in 2019, says Mailk.
11/05/18
MZHO
11/05/18
NO CHANGE
MZHO
Handset RF revenue expectations for 1H19 could see downside, says Mizuho
Mizuho analyst Vijay Rakesh says that while September quarter iPhone units were mostly in-line, Apple (AAPL) had a weaker December quarter guide at $89B-$93B, noting currency headwinds making iPhones costlier. The analyst would add that most consensus Apple iPhone estimates for December quarter are being lowered quarter over quarter post-call, a headwind for more exposed RF suppliers Skyworks (SWKS)/Qorvo (QRVO). Further, Rakesh highlights that Apple would not give color on iPhone/iPad units going forward, a headwind for suppliers with the lack of visibility, and with some of the weaker emerging market currencies the same $1000/$1400 Xs/Xs Max is selling at $1400/$1900 in China/Russia and East European countries. The analyst believes 1H19 handset RF revenue expectations could see downside as higher iPhone ASPs could be a challenge.
11/13/18
KEYB
11/13/18
NO CHANGE
Target $80
KEYB
Overweight
Qorvo price target lowered to $80 from $95 at KeyBanc
KeyBanc analyst John Vinh noted that Qorvo (QRVO) lowered its Q3 outlook due to recent iPhone demand changes, which he believes is largely related to disappointing demand for Apple's (AAPL) iPhone XR. He lowered his Qorvo estimates and cut his price target on the stock to $80 from $95, but keeps an Overweight rating on Qorvo shares, citing his belief that the company will benefit from RF content gain during the 5G transition.
AAPL Apple
$193.43

-0.725 (-0.37%)

11/13/18
CHLM
11/13/18
NO CHANGE
Target $60
CHLM
Buy
Lumentum price target lowered to $60 from $85 at Craig-Hallum
Craig-Hallum analyst Richard Shannon lowered his price target for Lumentum (LITE) to $60 from $85 saying its reduced Q2 guidance reflects lower Apple (AAPL) volumes, likely due to issues in China as well as the high ASP of those devices. The analyst believes 3DS remains an excellent area of growth with strong operating margins but the volatility of a single large customer and questions about its unit sell-through have clearly impacted the stock. Until he sees stronger unit demand from Android and Lumentum captures a strong share of that market, Shannon thinks the volatility will remain high. He reiterates a Buy rating on Lumentum shares.
11/13/18
MKMP
11/13/18
NO CHANGE
Target $60
MKMP
Buy
Lumentum price target lowered to $60 from $78 at MKM Partners
MKM Partners analyst Michael Genovese lowered his price target on Lumentum (LITE) to $60 after its negative pre-announcement reflecting an order cut from Apple (AAPL), adding that his average selling price assumptions suggest that the company is anticipating shipments of 30M 3D VCSELs vs. its original view of 50M. The analyst keeps his Buy rating on Lumentum however and contends that the 33% decline in its stock price on the news is overextended. Genovese further states that Lumentum remains the "strong technology and market share leader in the 3D VCSELs" and does not expect its market share to decline.
LITE Lumentum
$38.92

1.415 (3.77%)

11/13/18
11/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lumentum (LITE) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying yesterday's negative pronouncement underscored the challenges likely to be faced by Apple (AAPL) supply chain companies in delivering to investor expectations as Apple continues to prioritize its premium pricing strategy on iPhones relative to volumes. 2. Best Buy (BBY) downgraded to Neutral from Buy at BofA/Merrill with analyst Curtis Nagle citing expectations for slowing industry growth, difficult comps in key products and cost inflation. 3. Perrigo (PRGO) downgraded to Hold from Buy at Berenberg with analyst Patrick Trucchio saying although the key reason to own Perrigo shares remains intact, namely the U.S. government's push to shift more products from prescription to nonprescription, "too much uncertainty in generics has placed us on the sidelines." 4. Sabra Health Care (SBRA) downgraded to Neutral from Buy at Mizuho with analyst Richard Anderson saying he wants to a take a "pause" until the earnings reset from the "surprise news" of Senior Care stopping rent payments since May becomes better understood. 5. Infinera (INFN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Meta Marshall saying she sees "no reason to race in" until there are signs that the revenue base has stabilized. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/13/18
RILY
11/13/18
NO CHANGE
Target $74
RILY
Buy
Lumentum selloff overly discounts 3D sensing cycle, says B. Riley FBR
B. Riley FBR analyst Dave Kang believes the selloff yesterday in shares of Lumentum over discounts the multiyear 3D sensing cycle. The analyst lowered his price target for the shares to $74 from $88 and keeps a Buy rating on the name.
SWKS Skyworks
$72.16

-0.61 (-0.84%)

11/12/18
DADA
11/12/18
NO CHANGE
Target $115
DADA
Buy
Skyworks price target lowered to $115 from $125 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Skyworks to $115 after its disappointing outlook for Q1 that was attributed to lower smartphone unit sales and softness in the China market. The analyst notes that the weakness was "partially offset by continued strength in broad markets and the launch of a new high performance mobile solution". Diffely also keeps his Buy rating on Skyworks longer term, stating that the buildout of 5G as well as the continued development of Internet of Things and Mobility technology will "drive several years of growth".
11/12/18
SBSH
11/12/18
DOWNGRADE
SBSH
Neutral
Skyworks downgraded to Neutral from Buy at Citi
Citi analyst Atif Malik downgraded Skyworks Solutions to Neutral.
11/12/18
11/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Yelp (YELP) downgraded to Hold om Buy at SunTrust with analyst Matthew Thornton citing a surprising and disappointing set of Q3 results following a "stellar" first half of 2018, highlighted by the return of sales execution issues, yielding an unexpected slowdown in gross account adds and continued churn. 2. Cheesecake Factory (CAKE) downgraded to Underweight from Equal Weight at Barclays with analyst Jeffrey Bernstein saying he sees headwinds persisting following the company's "disappointing" Q3 results and views the valuation as full at current share levels. 3. Infinity Pharmaceuticals (INFI) downgraded to Underweight from Neutral at JPMorgan and to Market Perform at Wells Fargo. 4. Skyworks (SWKS) downgraded to Neutral from Buy at Citi with analyst Atif Malik saying the company is being impacted by broad smartphone weakness, disappointing unit sales of Apple's (AAPL) iPhone XR, and a high Apple concentration, which represented 39% of sales in fiscal 2019. 5. AB InBev (BUD) downgraded to Hold from Buy at Argus with analyst David Coleman citing the company's dividend cut, which he believes reduces the attraction of the stock to income investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CRUS Cirrus Logic
$37.63

1.99 (5.58%)

09/13/18
KEYB
09/13/18
NO CHANGE
KEYB
New Apple iPhone launch positive for Synaptics, Qorvo, says KeyBanc
KeyBanc analyst John Vinh notes that Apple (AAPL) revealed three new phones with incremental features and pricing largely consistent with his expectations. The analyst believes stocks best positioned to benefit from this upcoming cycle include Synaptics (SYNA), which supplies display drivers into the iPhone XR, and RF semiconductor suppliers, driven by content gains given increasing RF bands and enhanced wireless functionality. Vihn sees the new phone launch as most positive for Qorvo (QRVO), Skyworks (SWKS), and Synaptics. Conversely, the removal of the dongle from new and previous iPhones creates the most headwinds for Cirrus Logic (CRUS), he contends.
09/13/18
LEHM
09/13/18
NO CHANGE
LEHM
Underweight
Cirrus Logic's dongle removed from older iPhone models, says Barclays
Barclays analyst Blayne Curtis says his review of Apple's website reveals that Cirrus Logic's (CRUS) dongle is now removed from the entire suite of iPhones. Apple's (AAPL) website previously stated certain iPhones contained a "Lightning to 3.5mm Headphone Jack Adapter" in the box, but this has since been removed under each phone, Curtis tells investors in a research note. He views the development as an additional negative for Cirrus Logic. While the company already admitted that the dongle was out in current iPhone generations, the removal from older products could bring another $35M of downside in 2018 and $25M in 2019. The analyst keeps an Underweight rating on Cirrus Logic shares. The stock in late morning trading is down 2% to $40.08.
11/02/18
CHLM
11/02/18
NO CHANGE
Target $47
CHLM
Buy
Cirrus Logic price target cut to $47 from $51 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss reiterated a Buy rating on Cirrus Logic (CRUS) but lowered his price target to $47 after the company reported above consensus results but below consensus guidance on a pull in of orders from Apple (AAPL) from Q3 to Q2. Stoss notes that Cirrus would have only been slightly below on the guide if revenues were not pulled into the September quarter. While the analyst is setting his estimates conservatively lower, he tells investors in a research note that he believes there is upside to his March quarter estimates given expected content growth for Cirrus in the S10 as well as potential for better than expected iPhone sales. Further, Tony looks for Cirrus to return to y/y growth in FY20 driven by expansion at Samsung (SSNLF) as well as in China with their new haptic driver coming in 1H19.
09/12/18
CHLM
09/12/18
NO CHANGE
CHLM
Craig-Hallum likes Cypress, STMicroelectronics into Apple iPhone cycle
Ahead of Apple's (AAPL) new generation phone launch event today, Craig-Hallum analyst Anthony Stoss notes that all eyes will be on the rumored less expensive LCD phone that will still have infinity display. Stoss believes bulls on Apple are hopeful that the company could price the LCD phone around $600-$700, pushing iPhone sales above current consensus. On the flip side, a selling price of the LCD phone of $850 or more would be too high in the analyst's view and iPhone sales could be down year over year if that were the case. Stoss likes Cypress Semiconductor (CY), STMicroelectronics (STM), and Synaptics (SYNA) the most into this iPhone cycle, and sees potential upside to Cirrus Logic (CRUS) on a surprise inclusion of the dongle in any phone model's box.
AVGO Broadcom
$224.39

0.84 (0.38%)

11/08/18
DBAB
11/08/18
INITIATION
Target $310
DBAB
Buy
Broadcom resumed with a Buy at Deutsche Bank
Deutsche Bank analyst Ross Seymore resumed coverage of Broadcom with a Buy rating and $310 price target. The analyst believes the company's core semiconductor business possesses "leadership positions in a wide array of end markets."
11/08/18
JPMS
11/08/18
INITIATION
Target $325
JPMS
Overweight
Broadcom reinstated with an Overweight at JPMorgan
JPMorgan analyst Harlan Sur reinstated coverage of Broadcom with an Overweight rating and $325 price target following a period of restriction. Post the close of the CA acquisition, Broadcom team has created a "diversified technology powerhouse," Sur tells investors in a research note. He sees "several strong growth tailwinds" for the company heading into 2019.
11/08/18
11/08/18
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Stanley Black & Decker (SWK) initiated with a Hold at Deutsche Bank. 2. Comcast (CMCSA) resumed with an Overweight at Morgan Stanley while Amarin (AMRN) and Immunomedics (IMMU) were assumed with a Buy at the firm. 3. Broadcom (AVGO) resumed with a Buy at Deutsche Bank and reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/26/18
BNCH
10/26/18
NO CHANGE
Target $100
BNCH
Buy
Mellanox a 'prized' target for 'host of buyers,' says Benchmark
After CNBC reported that Mellanox (MLNX) has hired an advisor to explore strategic alternatives, including a possible sale, Benchmark analyst Gary Mobley said it is difficult to verify the story but he believes the company would "represent a prized M&A target for a host of buyers," including potentially Nvidia (NVDA), Intel (INTC), Broadcom (AVGO), Marvell (MRVL) and "even" IBM (IBM). The analyst, who added that Mellanox's "initial apathy" toward prior M&A talks with Marvell was part of the reason Starboard got involved, keeps a Buy rating on Mellanox shares with a $100 price target.

TODAY'S FREE FLY STORIES

03:50
12/17/18
12/17
03:50
12/17/18
03:50
General news
FX Action: USD-CAD has remained buoyant »

FX Action: USD-CAD has…

03:05
12/17/18
12/17
03:05
12/17/18
03:05
General news
FX Update: Narrow ranges have prevailed »

FX Update: Narrow ranges…

FII

Federated Investors

$24.65

-0.02 (-0.08%)

21:40
12/16/18
12/16
21:40
12/16/18
21:40
Initiation
Federated Investors initiated at Gabelli »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIII

G-III Apparel

$28.68

-0.29 (-1.00%)

21:37
12/16/18
12/16
21:37
12/16/18
21:37
Upgrade
G-III Apparel rating change at Stifel »

G-III Apparel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

21:34
12/16/18
12/16
21:34
12/16/18
21:34
Upgrade
Calyxt rating change at Goldman Sachs »

Goldman upgrades Calyxt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLXT

Calyxt

$9.88

0.4 (4.22%)

20:23
12/16/18
12/16
20:23
12/16/18
20:23
Upgrade
Calyxt rating change at Goldman Sachs »

Calyxt upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

, EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

20:08
12/16/18
12/16
20:08
12/16/18
20:08
Recommendations
Crestwood Equity, EQT Midstream Partners analyst commentary at Goldman Sachs »

Goldman upgrades…

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$131.02

-2.26 (-1.70%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Downgrade
Illinois Tool Works rating change at Deutsche Bank »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$118.36

0.46 (0.39%)

19:57
12/16/18
12/16
19:57
12/16/18
19:57
Upgrade
Stanley Black & Decker rating change at Deutsche Bank »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

, AET

Aetna

$0.00

(0.00%)

19:31
12/16/18
12/16
19:31
12/16/18
19:31
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

INCY

Incyte

$66.24

-1.04 (-1.55%)

AET

Aetna

$0.00

(0.00%)

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

HNT

Health Net

$0.00

(0.00%)

HUM

Humana

$300.41

-12.09 (-3.87%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

SNE

Sony

$51.32

-0.88 (-1.69%)

GOOG

Alphabet

$1,041.68

-21.44 (-2.02%)

GOOGL

Alphabet Class A

$1,050.62

-23.36 (-2.18%)

AAPL

Apple

$165.48

-5.45 (-3.19%)

BAC

Bank of America

$24.49

0.1 (0.41%)

BLK

BlackRock

$382.25

-5.29 (-1.37%)

CAT

Caterpillar

$126.78

0.79 (0.63%)

CVX

Chevron

$113.84

-2.15 (-1.85%)

DDAIF

Daimler AG

$0.00

(0.00%)

DAL

Delta Air Lines

$53.50

-0.03 (-0.06%)

ET

Energy Transfer LP

$14.08

-0.5 (-3.43%)

TOL

Toll Brothers

$32.23

-0.4 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 10

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 19

    Feb

  • 24

    Feb

  • 03

    Mar

EQT

EQT Corporation

$19.40

-0.78 (-3.87%)

18:54
12/16/18
12/16
18:54
12/16/18
18:54
Periodicals
EQT's board to seek meeting with Rice brothers, Reuters reports »

EQT Corporation's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

, EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

18:31
12/16/18
12/16
18:31
12/16/18
18:31
Downgrade
EQT Midstream Partners, EQGP Holdings rating change at Goldman Sachs »

EQT Midstream downgraded…

EQM

EQT Midstream Partners

$46.86

-0.1 (-0.21%)

EQGP

EQGP Holdings

$19.94

0.02 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEQP

Crestwood Equity

$32.29

0.47 (1.48%)

18:28
12/16/18
12/16
18:28
12/16/18
18:28
Upgrade
Crestwood Equity rating change at Goldman Sachs »

Crestwood Equity upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$66.24

-1.04 (-1.55%)

17:52
12/16/18
12/16
17:52
12/16/18
17:52
Hot Stocks
Innovent, Incyte announce agreement for three clinical-stage candidates in China »

Incyte and Innovent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

NSANY

Nissan

$0.00

(0.00%)

, RNLSY

Renault

$0.00

(0.00%)

17:14
12/16/18
12/16
17:14
12/16/18
17:14
Periodicals
Renault seeking Nissan shareholder meeting amid Ghosn crisis, Reuters says »

Renault (RNLSY) requested…

NSANY

Nissan

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

T

AT&T

$30.24

0.33 (1.10%)

, CMCSA

Comcast

$36.32

-0.43 (-1.17%)

16:48
12/16/18
12/16
16:48
12/16/18
16:48
Hot Stocks
Box Office Battle: 'Spider-Verse' wins weekend with $35M »

Sony's (SNE)…

T

AT&T

$30.24

0.33 (1.10%)

CMCSA

Comcast

$36.32

-0.43 (-1.17%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.32

-0.88 (-1.69%)

FOX

21st Century Fox

$48.79

-0.09 (-0.18%)

FOXA

21st Century Fox

$49.06

-0.07 (-0.14%)

LGF.A

Lionsgate

$15.59

-0.16 (-1.02%)

DIS

Disney

$112.21

-1.17 (-1.03%)

VIAB

Viacom

$28.56

-0.31 (-1.07%)

VIA

Viacom

$31.23

-0.4 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 30

    Jan

  • 20

    Mar

ELGX

Endologix

$0.71

0.0232 (3.39%)

16:17
12/16/18
12/16
16:17
12/16/18
16:17
Conference/Events
Endologix to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRPO

Precipio

$0.19

-0.0111 (-5.63%)

16:11
12/16/18
12/16
16:11
12/16/18
16:11
Conference/Events
Precipio to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSB

Mesabi Trust

$25.15

-1.1 (-4.19%)

16:08
12/16/18
12/16
16:08
12/16/18
16:08
Conference/Events
Mesabi Trust to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNT

Melinta Therapeutics

$1.19

-0.1 (-7.75%)

16:02
12/16/18
12/16
16:02
12/16/18
16:02
Conference/Events
Melinta Therapeutics to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$75.63

-1.32 (-1.72%)

15:55
12/16/18
12/16
15:55
12/16/18
15:55
Periodicals
Exxon Mobil shareholders call for greenhouse gas reduction targets, Reuters says »

A number of institutional…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$275.59

-4.93 (-1.76%)

, CNC

Centene

$127.55

-5.3 (-3.99%)

13:16
12/16/18
12/16
13:16
12/16/18
13:16
Periodicals
Health stocks preparing for market jolt after Obamacare ruling, Bloomberg says »

U.S. health-care stocks…

ANTM

Anthem

$275.59

-4.93 (-1.76%)

CNC

Centene

$127.55

-5.3 (-3.99%)

CI

Cigna

$205.34

-6.63 (-3.13%)

UNH

UnitedHealth

$265.06

-7.2 (-2.64%)

HUM

Humana

$300.41

-12.09 (-3.87%)

WCG

WellCare

$236.90

-7.44 (-3.04%)

MOH

Molina Healthcare

$131.72

-11.19 (-7.83%)

HNT

Health Net

$0.00

(0.00%)

AET

Aetna

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 05

    Feb

  • 19

    Feb

JELD

Jeld-Wen

$14.27

-0.46 (-3.12%)

13:02
12/16/18
12/16
13:02
12/16/18
13:02
Hot Stocks
Jeld-Wen announces final ruling in Steves & Sons litigation, to appeal decision »

Jeld-Wen announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRA

Atara Biotherapeutics

$41.78

-0.74 (-1.74%)

12:55
12/16/18
12/16
12:55
12/16/18
12:55
Hot Stocks
Atara Biotherapeutics presents positive efficacy, safety results for EBV + LMS »

Atara Biotherapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$133.95

2.595 (1.98%)

12:41
12/16/18
12/16
12:41
12/16/18
12:41
Hot Stocks
BeiGene announces updated Phase 1A/1B data on tislelizumab »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.